The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.
about
Pharmacology of manipulating lean body massAutophagy is essential to support skeletal muscle plasticity in response to endurance exerciseMultifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscleCellular and molecular mechanisms of muscle atrophyLeptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob miceOrg 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic indexβ-Hydroxy β-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD ratNoninvasive imaging of in vivo MuRF1 expression during muscle atrophyThe Signature of MicroRNA Dysregulation in Muscle Paralyzed by Spinal Cord Injury Includes Downregulation of MicroRNAs that Target Myostatin SignalingREDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle lossAging and the Mammalian regulatory triumvirateExtracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.Acute daily psychological stress causes increased atrophic gene expression and myostatin-dependent muscle atrophy.mRNA-seq reveals skeletal muscle atrophy in response to handling stress in a marine teleost, the red cusk-eel (Genypterus chilensis)Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitroFOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor.Estrogen-related receptor-α coordinates transcriptional programs essential for exercise tolerance and muscle fitness.Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcription factorsRegulation of large conductance Ca2+-activated K+ (BK) channel β1 subunit expression by muscle RING finger protein 1 in diabetic vessels.Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy.The mERG1a channel modulates skeletal muscle MuRF1, but not MAFbx, expression.Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration.Dexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance.SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophyCorticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylationSkeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1Forkhead box O1 and muscle RING finger 1 protein expression in atrophic and hypertrophic denervated mouse skeletal muscle.PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wastingNF-κB inhibition protects against tumor-induced cardiac atrophy in vivo.Myogenic and proteolytic mRNA expression following blood flow restricted exerciseMyotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphateThe regulation of muscle mass by endogenous glucocorticoids.p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle.Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models.Expression profiling identifies Klf15 as a glucocorticoid target that regulates airway hyperresponsiveness.Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
P2860
Q26824503-3B15BE88-7148-4CA2-BFCA-1AA0638DD5CCQ27000625-47BD8E08-4009-4115-A1CA-AE58D365D6CCQ27009396-F4DDF2D5-3CBB-46A4-9772-7A804257489FQ27012762-F5B319CB-03BC-4DAA-977F-D2E87A633BA0Q27342830-750E8D10-A117-4E14-868F-D4EF0CB0FF5BQ28485149-2AD16BAE-00DD-4811-BDBB-798B8E44667DQ28540883-47E4C75D-7FDA-4F17-937B-3280F2082858Q28542065-F306C0A1-76E7-4CEB-9056-1B073799B288Q28554674-E651FF7D-40C8-4C38-B122-1CFCA4BC74EAQ28573743-2C8976DD-0568-4031-9A4B-26E667410BD6Q28731496-FEBB3F6B-A2DD-45F3-8A9F-1B3D68F10581Q30405450-7E9D12AB-065C-41BC-9F0A-550DC6D2DBEAQ30496704-FDC91AD9-88C4-406B-A536-F13D7D72FA4FQ31029803-1F2FF957-3776-4C6B-95D8-D83380504630Q33517628-BFFDCAB9-F7F6-482C-A29B-BBCB2C5413B4Q33557470-51F27179-D54F-441A-B236-50889D76B65BQ33589260-53551504-CEAA-43D2-89C7-77A986B75D12Q33595368-2CF2E318-8E7F-47B4-BB55-BC84527E6EBAQ33631880-E9A5975E-D4E3-4D77-81DB-CCFAABF790EBQ33670466-191F5F4C-8274-45E6-AA73-03D37DBD618DQ33675897-C5F646E5-0A9A-4522-8718-00B099F61A07Q33707026-D6C11979-DB97-4FF9-98F7-7524986EEB2FQ33726235-C3E662C8-83B9-4B7C-8038-9CDBEEC359F8Q33751116-F0E4E52B-14D4-4939-A4CB-6FC83B831A5BQ33910776-2EC5331F-2E99-4166-95EE-CA56D7E9E2B4Q33952822-E633674D-63E3-4F3F-98EA-C19EE4100808Q34001370-CE59E636-6C52-4EBF-904D-524F16676118Q34017130-08C42B4D-8541-47F8-9842-4502DCC43E4DQ34115660-02E3805C-AA3A-43A7-8F4C-D37FF5C13558Q34200869-324FDB5A-F09D-4DA2-8625-169E1E5DEC39Q34256593-8FF0F009-A65E-4E73-938B-9D7DF37341BBQ34652034-3E5DC9A2-0F07-42A1-9828-6C85E916DC4AQ34760711-C91BABFC-F016-4AD2-9B17-00229788B266Q34985057-0AE77C6E-7943-4E23-8CD2-3EF9831D7134Q35011121-8281EA53-9586-4361-9AD5-6BE73862B896Q35042169-1A60885D-9EFF-4F6A-84BE-8950582B2CA4Q35055559-D80B19AE-C13A-40EE-98F4-AA583A6DB389Q35128706-8A592F20-90B0-4EFC-BA3F-39DDFF110186Q35219861-F40D1CA5-74FF-45D5-8D2F-9170E7AF7F98Q35341311-F2A6FC11-2428-4591-8106-C70CF5E42430
P2860
The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The glucocorticoid receptor an ...... atrophy-associated MuRF1 gene.
@en
The glucocorticoid receptor an ...... atrophy-associated MuRF1 gene.
@nl
type
label
The glucocorticoid receptor an ...... atrophy-associated MuRF1 gene.
@en
The glucocorticoid receptor an ...... atrophy-associated MuRF1 gene.
@nl
prefLabel
The glucocorticoid receptor an ...... atrophy-associated MuRF1 gene.
@en
The glucocorticoid receptor an ...... atrophy-associated MuRF1 gene.
@nl
P2093
P2860
P1476
The glucocorticoid receptor an ...... atrophy-associated MuRF1 gene
@en
P2093
David S Waddell
Holger M Reichardt
J David Furlow
Jens van den Brandt
Leslie M Baehr
P2860
P304
P356
10.1152/AJPENDO.00646.2007
P577
2008-07-08T00:00:00Z